These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cardiac differentiation of mouse embryonic stem cells is influenced by a PPAR γ/PGC-1α-FNDC5 pathway during the stage of cardiac precursor cell formation. Zadegan FG; Ghaedi K; Kalantar SM; Peymani M; Hashemi MS; Baharvand H; Nasr-Esfahani MH Eur J Cell Biol; 2015 Jun; 94(6):257-66. PubMed ID: 25936576 [TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model. Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation. De Nuccio C; Bernardo A; Cruciani C; De Simone R; Visentin S; Minghetti L Exp Neurol; 2015 Sep; 271():506-14. PubMed ID: 26210873 [TBL] [Abstract][Full Text] [Related]
13. Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease. Li J; Dai A; Hu R; Zhu L; Tan S Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):603-14. PubMed ID: 20732852 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons. Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533 [TBL] [Abstract][Full Text] [Related]
15. Two Rationally Identified Novel Glitazones Reversed the Behavioral Dysfunctions and Exhibited Neuroprotection Through Ameliorating Brain Cytokines and Oxy-Radicals in ICV-LPS Neuroinflammatory Rat Model. Justin A; Ashwini P; Jose JA; Jeyarani V; Dhanabal SP; Manisha C; Mandal SP; Bhavimani G; Prabitha P; Yuvaraj S; Prashantha Kumar BR Front Neurosci; 2020; 14():530148. PubMed ID: 33100954 [TBL] [Abstract][Full Text] [Related]
16. The neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent. Chiang MC; Cheng YC; Nicol CJ; Lin CH Int J Biochem Cell Biol; 2017 Nov; 92():121-133. PubMed ID: 28964868 [TBL] [Abstract][Full Text] [Related]
17. Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson's Disease. Prabhakaran P; Nadig A; M S; Tuladhar S; Raju RM; Chidambaram SB; Kempaiah BB; Raghavendra NM; Kumar Br P ACS Omega; 2023 Feb; 8(7):6825-6837. PubMed ID: 36844520 [TBL] [Abstract][Full Text] [Related]
18. PPAR(gamma)/PGC-1(alpha) pathway in E-cadherin expression and motility of HepG2 cells. Lee HJ; Su Y; Yin PH; Lee HC; Chi CW Anticancer Res; 2009 Dec; 29(12):5057-63. PubMed ID: 20044617 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the Nitrergic Pathway via Activation of PPAR-γ Contributes to the Neuroprotective Effect of Pioglitazone Against Streptozotocin-Induced Memory Dysfunction. Prakash A; Kumar A; Ming LC; Mani V; Majeed AB J Mol Neurosci; 2015 Jul; 56(3):739-50. PubMed ID: 25854775 [TBL] [Abstract][Full Text] [Related]
20. [Glitazones protects beta cell function from cytotoxic cytokines through PPAR gamma-dependent mechanisms]. Li X; Wang AP; Yan X; Huang G; Liu BL; Zhou ZG Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1530-3. PubMed ID: 20650758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]